Hydrogen Capsules Reduce Chronic Inflammation in New Study

Summary by Hydrogen Studies Editorial Team · Updated

Authors
Journal
International Journal of Medical Sciences
Year
DOI
10.7150/ijms.101114
Study Type
Human
Outcome
Positive
Peer Reviewed
Yes
Country
Taiwan
Health Condition
Chronic Inflammation
Body System
Immune System

TL;DR

Taking oral solid hydrogen capsules (OSHCs) may help reduce inflammation and improve health in people with chronic inflammatory diseases.

Key Finding

In a small 4-week pilot study, people taking high-dose oral hydrogen capsules showed a significant reduction in ESR (a blood inflammation marker), with dose-dependent effects observed.

Summary

This pilot study examined whether oral solid hydrogen capsules (OSHCs)—a form of molecular hydrogen supplement—could reduce inflammation in 30 people with chronic inflammatory conditions over 4 weeks. Researchers measured inflammation markers in the blood (ESR and CRP) and symptoms like fatigue and disease activity. The high-dose group showed a significant decrease in one inflammation marker (ESR), and overall inflammation markers trended downward, with improvements also seen in fatigue and disease control scores.

Practical Takeaway

This early-stage human study suggests hydrogen capsules may have anti-inflammatory potential, but the study was small (30 people), short-term (4 weeks), and lacked a control group, making it impossible to know if improvements were due to the hydrogen or other factors. Larger, well-controlled trials are needed before drawing any conclusions about whether hydrogen supplements could help manage chronic inflammation.

Abstract (excerpt)

Background: Persistent inflammation over time can cause gradual harm to the body. Molecular hydrogen has the potential to specifically counteract reactive oxygen species (ROS), reduce disease severity, and enhance overall health. Investigations of the anti-inflammatory and antioxidant properties…

Read the full abstract via DOI